Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...

TEDCO, Maryland's economic engine for technology companies, announced the next round of Maryland Innovation Initiative ...

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) </ ...

It is sad to see pets die of something easily preventable. It's even worse knowing that the owner was misinformed or misled ...

It helps you build strength,' how playing football helped one CSU Pueblo student athlete beat cancer and return to the field.

After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care ...

which expects an FDA decision in April 2023 on its C. Difficile treatment, Ser-109. Also notable among the many innovations which could be approved in 2023 is significant progress in Respiratory ...

If your UTI symptoms persist or get worse, you should seek medical treatment. In addition to an antibiotic ... (infections that do not respond to antibiotics) Clostridioides difficile (C. diff) ...

Tinidazole was approved by the FDA in May 2004 for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.

The advocacy group Prisoners’ Legal Services of Massachusetts filed a federal class action lawsuit on Wednesday, claiming the Essex County sheriff is denying hepatitis C treatment to people in their ...